Amos CI - Search Results

1

Predictors of disease aggressiveness influence outcome from immunotherapy treatment in renal clear cell carcinoma.

Kamal Y, Cheng C, Frost HR, Amos CI. Kamal Y, et al. Among authors: amos ci. Oncoimmunology. 2018 Oct 16;8(1):e1500106. doi: 10.1080/2162402X.2018.1500106. eCollection 2019. Oncoimmunology. 2018. PMID: 30546942 Free PMC article.

2

A global test for gene-gene interactions based on random matrix theory.

Frost HR, Amos CI, Moore JH. Frost HR, et al. Among authors: amos ci. Genet Epidemiol. 2016 Dec;40(8):689-701. doi: 10.1002/gepi.21990. Epub 2016 Jul 7. Genet Epidemiol. 2016. PMID: 27386793 Free PMC article.

3

Unsupervised gene set testing based on random matrix theory.

Frost HR, Amos CI. Frost HR, et al. Among authors: amos ci. BMC Bioinformatics. 2016 Nov 4;17(1):442. doi: 10.1186/s12859-016-1299-8. BMC Bioinformatics. 2016. PMID: 27809777 Free PMC article.

4

Population effect model identifies gene expression predictors of survival outcomes in lung adenocarcinoma for both Caucasian and Asian patients.

Cai G, Xiao F, Cheng C, Li Y, Amos CI, Whitfield ML. Cai G, et al. Among authors: amos ci. PLoS One. 2017 Apr 20;12(4):e0175850. doi: 10.1371/journal.pone.0175850. eCollection 2017. PLoS One. 2017. PMID: 28426704 Free PMC article.

5

Gene set selection via LASSO penalized regression (SLPR).

Frost HR, Amos CI. Frost HR, et al. Among authors: amos ci. Nucleic Acids Res. 2017 Jul 7;45(12):e114. doi: 10.1093/nar/gkx291. Nucleic Acids Res. 2017. PMID: 28472344 Free PMC article.

6

A P53-Deficiency Gene Signature Predicts Recurrence Risk of Patients with Early-Stage Lung Adenocarcinoma.

Zhao Y, Varn FS, Cai G, Xiao F, Amos CI, Cheng C. Zhao Y, et al. Among authors: amos ci. Cancer Epidemiol Biomarkers Prev. 2018 Jan;27(1):86-95. doi: 10.1158/1055-9965.EPI-17-0478. Epub 2017 Nov 15. Cancer Epidemiol Biomarkers Prev. 2018. PMID: 29141854 Free PMC article.

7

Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy.

Varn FS, Tafe LJ, Amos CI, Cheng C. Varn FS, et al. Among authors: amos ci. Oncoimmunology. 2018 Mar 15;7(6):e1431084. doi: 10.1080/2162402X.2018.1431084. eCollection 2018. Oncoimmunology. 2018. PMID: 29872556 Free PMC article.

8

A Leukocyte Infiltration Score Defined by a Gene Signature Predicts Melanoma Patient Prognosis.

Zhao Y, Schaafsma E, Gorlov IP, Hernando E, Thomas NE, Shen R, Turk MJ, Berwick M, Amos CI, Cheng C. Zhao Y, et al. Among authors: amos ci. Mol Cancer Res. 2019 Jan;17(1):109-119. doi: 10.1158/1541-7786.MCR-18-0173. Epub 2018 Aug 31. Mol Cancer Res. 2019. PMID: 30171176 Free PMC article.

9

Gene characteristics predicting missense, nonsense and frameshift mutations in tumor samples.

Gorlov IP, Pikielny CW, Frost HR, Her SC, Cole MD, Strohbehn SD, Wallace-Bradley D, Kimmel M, Gorlova OY, Amos CI. Gorlov IP, et al. Among authors: amos ci. BMC Bioinformatics. 2018 Nov 19;19(1):430. doi: 10.1186/s12859-018-2455-0. BMC Bioinformatics. 2018. PMID: 30453881 Free PMC article.

10

Statins associate with improved mortality among patients with certain histological subtypes of lung cancer.

Ung MH, MacKenzie TA, Onega TL, Amos CI, Cheng C. Ung MH, et al. Among authors: amos ci. Lung Cancer. 2018 Dec;126:89-96. doi: 10.1016/j.lungcan.2018.10.022. Epub 2018 Oct 25. Lung Cancer. 2018. PMID: 30527197 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

863 results

Search Page

Filters